Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 30%?

Yahoo FinanceDec 23 21:42

PANTHERx Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA (Olezarsen)

PR NewswireDec 23 21:42

Piper Sandler Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $62

Futu NewsDec 23 20:31 · Ratings

Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51

Futu NewsDec 23 18:31 · Ratings

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)

TipRanksDec 23 17:40 · Ratings

Express News | Ionis Pharmaceuticals Inc : Oppenheimer Raises Target Price to $78 From $75

BreakingsDec 23 13:26